申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2012098070A1
                            
                            
                                公开(公告)日:2012-07-26
                            
                            Compounds of Formula (I) and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.